{"id":120497,"date":"2014-03-31T20:45:22","date_gmt":"2014-04-01T00:45:22","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/proove-biosciences-is-now-a-member-of-the-personalized-medicine-coalition.php"},"modified":"2014-03-31T20:45:22","modified_gmt":"2014-04-01T00:45:22","slug":"proove-biosciences-is-now-a-member-of-the-personalized-medicine-coalition","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/genetic-medicine\/proove-biosciences-is-now-a-member-of-the-personalized-medicine-coalition.php","title":{"rendered":"Proove Biosciences Is Now a Member of The Personalized Medicine Coalition"},"content":{"rendered":"<p><p>    IRVINE, CA and FULTON, MD (PRWEB) March 31, 2014  <\/p>\n<p>        Proove Biosciences, the leading personalized pain medicine    laboratory, is proud to announce its membership in the     Personalized Medicine Coalition, a unique organization    created to advance personalized medicine as a viable solution    to the challenges of healthcare safety, efficiency, and cost.  <\/p>\n<p>        Proove Biosciences leads the industry in scientifically    driven genetic pain medicine research, and has presented    findings on how genetic analysis can help physicians make more    informed and efficient decisions on pain treatments. Over the    last three years     the companys genetic testing services have helped    physicians analyze patients risk profile for developing    prescription narcotic dependencies, as well as which    medications will be most effective in treating their pain.  <\/p>\n<p>    We are tremendously excited to be a member of the     Personalized Medicine Coalition, and contribute towards the    advancement of realizing personal medicines life-changing    potential, stated Proove Biosciences founder and CEO, Brian    Meshkin. As a member of PMC, we are looking forward to    collaborating and working along side industry leaders to shape,    promote, and foster new mediums that will strengthen    personalized medicines market viability through policy    initiatives and public support.  <\/p>\n<p>        Proove Founder and CEO Brian Meshkin has also been    appointed to both the Science Policy and Public Policy    committees of the Personalized Medicine Coalition. Brian brings    extensive background conducting scientific research in the    field of personalized medicine, having developed the worlds    largest practice-based evidence (PBE) database of personalized    pain medicine and being an author on over 15 publications in    peer-reviewed medical journals. His first publication was in    Mutation Research in 2005 outlining the proofs of principle in    pharmacogenetics and laying out, for the first time, a    pharmacoeconomic model for demonstrating the benefits of    personalized medicine testing. Additionally, Brian has a    background in public policy, having recently served as an    elected official in the State of Maryland and having    successfully lobbied as a citizen for various pieces of    legislation. Currently, he serves on the Board of Education of    Howard County, Maryland.  <\/p>\n<p>    About The Personalized Medicine Coalition    The Personalized Medicine Coalition (PMC) was launched in 2004    to educate the public and policymakers, and to promote new ways    of thinking about health care. Today, PMC represents a broad    spectrum of more than 225 innovator, academic, industry,    patient, provider and payer communities, as we seek to advance    the understanding and adoption of personalized medicine    concepts and products for the benefit of patients.  <\/p>\n<p>    About Proove Biosciences    Proove Biosciences is the leading personalized pain medicine    laboratory that provides proprietary genetic testing services    to help physicians improve outcomes for patients and contain    costs for insurers. With offices in Southern California and the    Baltimore-Washington metropolitan area, the company is the    research leader investigating and publishing data on the    genetics of pain medicine with clinical research sites across    the United States. Physicians use Proove Biosciences testing to    improve pain medicine selection, dosing, and evaluation of    medications they prescribe. From a simple cheek swab collected    in the office, Proove performs proprietary genetic tests in its    CLIA-certified laboratory to identify patients at risk for    misuse of prescription pain medications and evaluate their    metabolism of medications. For more information, please visit        <a href=\"http:\/\/www.proovebio.com\" rel=\"nofollow\">http:\/\/www.proovebio.com<\/a> or call toll free 855-PROOVE-BIO    (855-776-6832).  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Go here to read the rest:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/www.prweb.com\/releases\/2014\/03\/prweb11717536.htm\/RS=^ADAlSvxtKCIHOmF_wluve5KT.s2yQ8-\" title=\"Proove Biosciences Is Now a Member of The Personalized Medicine Coalition\">Proove Biosciences Is Now a Member of The Personalized Medicine Coalition<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> IRVINE, CA and FULTON, MD (PRWEB) March 31, 2014 Proove Biosciences, the leading personalized pain medicine laboratory, is proud to announce its membership in the Personalized Medicine Coalition, a unique organization created to advance personalized medicine as a viable solution to the challenges of healthcare safety, efficiency, and cost.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/genetic-medicine\/proove-biosciences-is-now-a-member-of-the-personalized-medicine-coalition.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[5],"tags":[],"class_list":["post-120497","post","type-post","status-publish","format-standard","hentry","category-genetic-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/120497"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=120497"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/120497\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=120497"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=120497"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=120497"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}